Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Imclone Systems Inc/de

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Imclone Systems Inc/de in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Imclone Systems Inc/de since year 2005. Table 2 shows the detailed insider transactions of Imclone Systems Inc/de since 2005. The reporting company's ticker symbol is IMCL. The reporting company's CIK number is 765258.

The total value of stock buying since 2005 is $88,173,167. The total value of stock sales is $9,927,164. The total value of stock exercises is $2,639,747.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at Imclone Systems Inc/de (IMCL) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • $2,870k

    $287k

    $28k

    $2k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Imclone Systems Inc/de (IMCL) in the past 24 months. See table 2 for insider transaction details.

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • $64.40

    $48.30

    $32.20

    $16.10



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Imclone Systems Inc/de (IMCL).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-09 0 0 11,957 770,030 11,957 334,048
2008-08 0 0 0 0 7,837 0
2008-07 0 0 15,000 962,400 41,707 1,349,922
2008-02 0 0 0 0 10,528 0
2007-11 0 0 47,814 2,870,859 9,150 86,238
2007-09 13,609 499,994 0 0 0 0
2007-07 0 0 1,250 42,750 1,250 13,250
2006-10 0 0 25,436 769,739 25,000 173,499
2006-09 641,200 19,188,180 0 0 0 0
2006-08 2,319,872 66,282,527 39,158 1,264,959 34,534 371,573
2006-07 0 0 6,000 232,525 6,000 24,285
2006-06 0 0 7,250 289,431 7,250 35,190
2006-05 51,027 1,918,759 11,000 416,149 11,000 56,640
2006-04 6,500 241,539 14,585 492,583 9,000 61,630
2006-03 1,000 38,190 10,000 345,000 10,000 35,312
2006-01 0 0 20,000 716,073 20,000 89,720
2005-12 0 0 2,000 70,000 2,000 8,440
2005-11 0 0 21,426 684,666 0 0
2004-07 60 3,978 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Imclone Systems Inc/de (IMCL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-09-02 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 11,957 64.40 770,030
2008-09-02 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 11,957 27.94 334,048
2008-08-27 Johnson John H (CEO) Option Exercise 7,837 .00 0
2008-07-31 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 15,000 64.16 962,400
2008-07-31 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 26,957 29.88 805,340
2008-07-31 Bailey Michael P (SVP, Commercial Ops) Option Exercise 14,750 36.92 544,582
2008-02-15 Mayes, Gregory T. (VP, Interim General Counsel) Option Exercise 1,360 .00 0
2008-02-15 Crowley Richard (SVP, Biopharmaceuctical Ops) Option Exercise 2,667 .00 0
2008-02-15 Rowinsky Eric K (SVP, Chief Medical Officer) Option Exercise 2,667 .00 0
2008-02-15 Bailey Michael P (SVP, Commercial Ops) Option Exercise 2,667 .00 0
2008-02-15 Borzilleri Peter R (Interim VP, Finance) Option Exercise 1,167 .00 0
2007-11-19 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 21,107 53.40 1,157,408
2007-11-19 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 9,150 9.42 86,238
2007-11-19 Bailey Michael P (SVP, Commercial Ops) Sale 14,750 64.16 946,290
2007-09-07 Johnson John H (CEO) Purchase 13,609 36.74 499,994
2007-07-12 Bailey Michael P (SVP, Commercial Ops) Sale 1,250 34.20 42,750
2007-07-12 Bailey Michael P (SVP, Commercial Ops) Option Exercise 1,250 10.60 13,250
2006-10-13 Ramanathan Erik (Senior Vice President, Legal) Sale 9,996 30.90 308,876
2006-10-13 Ramanathan Erik (Senior Vice President, Legal) Option Exercise 9,996 6.94 69,372
2006-10-10 Ramanathan Erik (Senior Vice President, Legal) Sale 5,004 30.92 154,734
2006-10-10 Ramanathan Erik (Senior Vice President, Legal) Option Exercise 5,004 6.94 34,727
2006-10-05 Howerton Michael (SVP, Chief Financial Officer) Sale 10,436 29.33 306,129
2006-10-05 Howerton Michael (SVP, Chief Financial Officer) Option Exercise 10,000 6.94 69,400
2006-09-14 Beckton Corp (10% Owner) Purchase 41,200 30.15 1,242,180
2006-09-13 Beckton Corp (10% Owner) Purchase 600,000 29.91 17,946,000
2006-08-28 Ramanathan Erik (SVP, Secretary & Gen Counsel) Sale 5,000 30.19 150,948
2006-08-28 Ramanathan Erik (SVP, Secretary & Gen Counsel) Option Exercise 5,000 6.94 34,700
2006-08-28 Beckton Corp (10% Owner) Purchase 15,745 30.12 474,239
2006-08-25 Howerton Michael (SVP, Chief Financial Officer) Sale 6,250 30.01 187,591
2006-08-25 Howerton Michael (SVP, Chief Financial Officer) Option Exercise 6,250 11.91 74,437
2006-08-25 Beckton Corp (10% Owner) Purchase 66,904 29.98 2,005,781
2006-08-24 Beckton Corp (10% Owner) Purchase 91,242 29.98 2,735,435
2006-08-22 Beckton Corp (10% Owner) Purchase 176,042 29.98 5,277,739
2006-08-21 Beckton Corp (10% Owner) Purchase 23,000 29.96 689,080
2006-08-18 Beckton Corp (10% Owner) Purchase 119,187 29.97 3,572,034
2006-08-17 Beckton Corp (10% Owner) Purchase 77,100 29.55 2,278,305
2006-08-16 Beckton Corp (10% Owner) Purchase 104,222 28.96 3,018,269
2006-08-15 Beckton Corp (10% Owner) Purchase 266,009 28.46 7,570,616
2006-08-14 Beckton Corp (10% Owner) Purchase 250,000 28.67 7,167,500
2006-08-11 Beckton Corp (10% Owner) Purchase 1,130,421 27.86 31,493,529
2006-08-04 Martell Ron (Former SVP, Commercial Ops) Sale 9,000 33.48 301,284
2006-08-04 Martell Ron (Former SVP, Commercial Ops) Option Exercise 9,000 6.94 62,460
2006-08-03 Martell Ron (Former SVP, Commercial Ops) Sale 18,908 33.06 625,136
2006-08-03 Martell Ron (Former SVP, Commercial Ops) Option Exercise 14,284 14.00 199,976
2006-07-03 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 1,000 38.68 38,675
2006-07-03 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 1,000 6.94 6,940
2006-07-03 Devita Vincent (Director) Sale 5,000 38.77 193,850
2006-07-03 Devita Vincent (Director) Option Exercise 5,000 3.47 17,345
2006-06-21 Ramanathan Erik (SVP, Secretary & Gen Counsel) Sale 1,250 40.00 50,000
2006-06-21 Ramanathan Erik (SVP, Secretary & Gen Counsel) Option Exercise 1,250 10.60 13,250
2006-06-01 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 1,000 39.84 39,840
2006-06-01 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 1,000 6.94 6,940
2006-06-01 Devita Vincent (Director) Sale 5,000 39.92 199,591
2006-06-01 Devita Vincent (Director) Option Exercise 5,000 3.00 15,000
2006-05-15 Tarnowski S Joseph (Other) Purchase 3,500 42.12 147,428
2006-05-12 Howerton Michael (SVP, Chief Financial Officer) Sale 2,800 40.00 112,000
2006-05-12 Howerton Michael (SVP, Chief Financial Officer) Option Exercise 2,800 6.94 19,432
2006-05-10 Howerton Michael (SVP, Chief Financial Officer) Sale 2,200 40.00 88,000
2006-05-10 Howerton Michael (SVP, Chief Financial Officer) Option Exercise 2,200 6.94 15,268
2006-05-05 Beckton Corp (10% Owner) Purchase 47,527 37.27 1,771,331
2006-05-01 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 1,000 35.96 35,960
2006-05-01 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 1,000 6.94 6,940
2006-05-01 Devita Vincent (Director) Sale 5,000 36.04 180,189
2006-05-01 Devita Vincent (Director) Option Exercise 5,000 3.00 15,000
2006-04-24 Tarnowski S Joseph (Other) Purchase 6,500 37.16 241,539
2006-04-21 Crowley Richard (SVP, Biopharmaceutical Ops) Sale 1,000 35.00 35,000
2006-04-21 Crowley Richard (SVP, Biopharmaceutical Ops) Option Exercise 1,000 6.94 6,940
2006-04-17 Fazio John A (Director) Sale 3,000 32.82 98,453
2006-04-17 Fazio John A (Director) Option Exercise 3,000 13.23 39,690
2006-04-12 Martell Ron (SVP, Commercial Operations) Sale 5,585 32.97 184,130
2006-04-04 Devita Vincent (Director) Sale 5,000 35.00 175,000
2006-04-04 Devita Vincent (Director) Option Exercise 5,000 3.00 15,000
2006-03-20 Devita Vincent (Director) Sale 10,000 34.50 345,000
2006-03-20 Devita Vincent (Director) Option Exercise 10,000 3.53 35,312
2006-03-02 Tarnowski S Joseph (Other) Purchase 1,000 38.19 38,190
2006-01-30 Devita Vincent (Director) Sale 19,000 35.85 681,073
2006-01-30 Devita Vincent (Director) Option Exercise 19,000 4.50 85,500
2006-01-17 Tarnowski S Joseph (SVP, Manufacturing,) Sale 1,000 35.00 35,000
2006-01-17 Tarnowski S Joseph (SVP, Manufacturing,) Option Exercise 1,000 4.22 4,220
2005-12-27 Tarnowski S Joseph (SVP, Manufacturing,) Sale 2,000 35.00 70,000
2005-12-27 Tarnowski S Joseph (SVP, Manufacturing,) Option Exercise 2,000 4.22 8,440
2005-11-17 Martell Ron (SVP, Commercial Oper) Sale 14,284 31.96 456,444
2004-07-23 Stancic Ana (Chief Accounting Officer) Purchase 60 66.30 3,978

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Imclone Systems Inc/de (symbol IMCL, CIK number 765258) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.